Neil Drake Insider Trading $OBLN ReShape Lifesciences Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Neil Drake.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neil Drake. Neil Drake is in OBALON THERAPEUTICS INC ($OBLN) and VP Research and Development in OBALON THERAPEUTICS INC ($OBLN).
Neil Drake in ReShape Lifesciences Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Neil Drake: VP Research and Development
Holdings: 61,267 shares
Current Value: $585,713
Latest Transaction: Jan 04 2019
$OBLN Market Capitalization: $158.66M
$OBLN Previous Close: $9.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Neil Drake in ReShape Lifesciences Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2019 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Option Exercise | A | 2.30 | 35,000 | 80,500 | 35,000 | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Grant | A | 1.82 | 13,736 | 25,000 | 61,267 | 47.5 K to 61.3 K (+28.90 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Grant | A | 1.82 | 13,736 | 25,000 | 61,267 | 47.5 K to 61.3 K (+28.90 %) |
| May 17 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Grant | A | 0.00 | 17,938 | 0 | 17,938 | 0 to 17.9 K |
| May 02 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Grant | A | 3.27 | 2,743 | 8,970 | 29,593 | 26.9 K to 29.6 K (+10.22 %) |
| Mar 19 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Buy | P | 3.96 | 5,000 | 19,778 | 26,850 | 21.9 K to 26.9 K (+22.88 %) |
| Feb 05 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Option Exercise | M | 1.77 | 4,310 | 7,629 | 6,034 | |
| Feb 05 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Option Exercise | M | 0.76 | 3,641 | 2,767 | 1,083 | |
| Feb 05 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Option Exercise | M | 1.83 | 5,746 | 10,515 | 0 | |
| Feb 05 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Option Exercise | M | 1.31 | 229 | 300 | 0 | |
| Feb 05 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Buy | M | 1.77 | 4,310 | 7,629 | 21,850 | 17.5 K to 21.9 K (+24.57 %) |
| Feb 05 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Buy | M | 0.76 | 3,641 | 2,767 | 17,540 | 13.9 K to 17.5 K (+26.20 %) |
| Feb 05 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Buy | M | 1.83 | 5,746 | 10,515 | 13,899 | 8.2 K to 13.9 K (+70.48 %) |
| Feb 05 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Buy | M | 1.31 | 229 | 300 | 8,153 | 7.9 K to 8.2 K (+2.89 %) |
| Jan 04 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Option Exercise | A | 7.15 | 35,000 | 250,250 | 35,000 | |
| Nov 02 2017 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Grant | A | 7.17 | 1,743 | 12,497 | 7,924 | 6.2 K to 7.9 K (+28.20 %) |
| May 02 2017 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | Grant | A | 9.03 | 1,661 | 14,999 | 6,181 | 4.5 K to 6.2 K (+36.75 %) |
Page: 1